The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular testing and patterns of treatment in patients with NSCLC: An IASLC analysis of ASCO CancerLinQ Discovery Data.
 
Madhusmita Behera
No Relationships to Disclose
 
Gregory Joseph
No Relationships to Disclose
 
Manali Rupji
No Relationships to Disclose
 
Zhonglu Huang
No Relationships to Disclose
 
Becky Bunn
No Relationships to Disclose
 
Murry Wynes
Consulting or Advisory Role - AstraZeneca
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
Giorgio V. Scagliotti
Honoraria - AstraZeneca; Johnson & Johnson/Janssen; Lilly; MSD Oncology; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; BeiGene; Lilly
Speakers' Bureau - AstraZeneca; beigene; Roche
Travel, Accommodations, Expenses - Bayer
 
Kristin Ann Higgins
Honoraria - PrecisCA
Consulting or Advisory Role - AstraZeneca; Genentech; Varian Medical Systems
Research Funding - Jazz Pharmaceuticals; Reflexion Medical
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca
 
Ming Sound Tsao
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Lilly
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst)
 
Chandra Prakash Belani
Consulting or Advisory Role - Genentech/Roche; OncoCyte; Sanofi/Aventis
Travel, Accommodations, Expenses - Genentech/Roche; Takeda
 
Lecia V. Sequist
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Janssen Oncology; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Cullinan Oncology (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Delfi Diagnostics (Inst); Genentech (Inst); Johnson & Johnson (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Suresh S. Ramalingam
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; GlaxoSmithKline; Lilly/ImClone; Merck; Mirati Therapeutics; Takeda
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - American Cancer Society